Follow me on Twitter

I agree that content from Twitter will be displayed to me.

 

Head of Group
Director of Corporate Program

His main research interests are ligand- and structure-based drug design with focus on transmembrane transport proteins, prediction of on- and off-kinetics, as well as semantic data integration.

Contact Hours for Students

  • Wednesday 14:00 - 15:00
  • Room 2E405 (or online) 
  • only after appointment via E-Mail latest on Friday before
Publications

Fürst, R, Nowikow, C, Berenyi, A, Ecker, GF, Schmid, W, Zupko, I & Rinner, DIU 2010, 'Synthesis and biological evaluation of novel carbocycle-containing combretastatin A-4 analogs', American Chemical Society. Abstracts of Papers (at the National Meeting), vol. 240.

Sugano, K, Kansy, M, Artursson, P, Avdeef, A, Bendels, S, Di, L, Ecker, GF, Faller, B, Fischer, H, Gerebtzoff, G, Lennernaes, H & Senner, F 2010, 'Coexistence of passive and carrier-mediated processes in drug transport', Nature Reviews. Drug Discovery, vol. 9, no. 8, pp. 597-614. https://doi.org/10.1038/nrd3187

Augustyns, K & Ecker, G 2010, 'Medicinal Chemistry in the 21st Century', MedChemComm, vol. 1, no. 1, pp. B5-B7.

Activities

Showing entries 1 - 5 out of 207

AI in Drug Discovery and Toxicity Prediction

Gerhard Ecker
ARUA 2025
Conference, Talk or oral contribution
30.10.2025 - 30.10.2025

In silico MIE Prediction

Gerhard Ecker
RISK-HUNT3R Stakeholder Symposium
Conference, Talk or oral contribution
18.6.2025 - 18.6.2025

Prediction of Toxicity

Gerhard Ecker
CCC-Trio 2025
Conference, Talk or oral contribution
12.6.2025 - 12.6.2025

Prediction of Toxicity - let's use Fingerprints

Gerhard Ecker
OpenTox Virtual Conference 2024
Conference, Talk or oral contribution
29.11.2024 - 29.11.2024

In silica prediction of toxicity - from QSAR models to biological fingerprinting

Gerhard Ecker
AAPR 23 - patterns in one health
Conference, Talk or oral contribution
25.10.2023 - 25.10.2023